Gastroenteritis / Stomach Flu Pipeline (Therapeutics by Drug Target, MoA, RoA, Molecule Type) H1 2015 Review Report

May 27, 2015, 09:00 ET from ReportsnReports

DALLAS, May 27, 2015 /PRNewswire/ --

The 'Gastroenteritis - Pipeline Review, H1 2015' market research report provides an overview of the Gastroenteritis's (stomach flu) therapeutic pipeline and comprehensive information on the therapeutic development for Gastroenteritis.

Complete report on gastroenteritis pipeline spread across 50 pages, providing analysis of 4 major companies and supported with 19 tables and 14 figures is now available at .

This gastroenteritis report provides comprehensive information on the therapeutic development for Gastroenteritis / stomach flue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastroenteritis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

This gastroenteritis research provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies. It helps identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. The information on the gastroenteritis therapeutic products under development also provides an overview to develop strategic initiatives by understanding the focus areas of leading companies. Readers can plan mergers and acquisitions effectively by identifying key players of the most promising pipeline. Devising corrective measures for pipeline projects by understanding Gastroenteritis pipeline depth and focus of Indication therapeutics becomes easier. This research on gastroenteritis / stomach flu also helps develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope while simultaneously helping to modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies like Cocrystal Pharma, Inc., RedHill Biopharma Ltd., Takeda Pharmaceutical Company Limited and UMN Pharma Inc. are mentioned in this research. The report also provides drug profiles for Antibodies for Gastroenteritis, Antibody to Target TRIM-21 for Gastrointestinal and Ear Nose Throat Disorders, Small Molecules to Inhibit RNA Dependent RNA Polymerase for Acute Gastroenteritis, TAK-214, UMN-2002 and UMN-2003. Order a copy of Gastroenteritis - Pipeline Review, H1 2015 market research report at .

The report provides a snapshot of the global therapeutic landscape of Gastroenteritis as well as reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. The stomach flu research reviews key players involved in the therapeutics development for Gastroenteritis and enlists all their major and minor projects while summarizing all the dormant and discontinued pipeline projects. A review of the Gastroenteritis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources is provided along with pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages. A detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the gastroenteritis pipeline on the basis of target, MoA, route of administration and molecule type as well as latest news and deals relating related to pipeline products are also covered in this gastroenteritis research.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by an expert team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. has multiple newly published research reports on pharmaceuticals market as well as the related medical devices industry:

Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Stomach, Small Intestine, Large Intestine) & Geography - Global Forecast to 2024: The smart pills market is segmented on the basis of applications and regions. On the basis of applications, capsule endoscopy accounted for the largest share of the smart pills market in 2014. On the basis of regions, North America is expected to grow at the highest CAGR during the forecast period. The high growth of this region can be attributed to the favorable reimbursement scenario, FDA approvals for smart pills, and investment by government and other agencies.

The smart pills market has few players as two major segments of the market are under R&D phase. The companies in this market focus on growth strategies such as new product launches; agreements, partnerships, collaborations, and others (approvals and expansion) to increase their customer base. The major players in the global smart pills market include CapsoVision, Inc. (U.S.), Given Imaging, Inc. (Israel), Medimetrics C.V. (Mexico), Olympus Corporation (Japan), and Bio-Images Research Limited (U.K.). Read more at .

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Connect With Us on:  




G+/Google Plus:



Ritesh Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441  

SOURCE ReportsnReports